IL262892A
(en )
2018-12-31
Anti pd-1 and anti-lag3 antibodies for cancer treatment
IL267803A
(en )
2019-09-26
Methods of treating cancer with anti-tim-3 antibodies
HK1251474A1
(en )
2019-02-01
Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonists
HK1252272A1
(en )
2019-05-24
Methods of treating cancer using anti-ox40 antibodies
IL263178A
(en )
2018-12-31
Pd-1 / pd-l1 inhibitors for cancer treatment
IL265541B2
(en )
2024-08-01
Bispecific antibodies and compositions comprising thereof for treating cancer
ZA201904316B
(en )
2022-12-21
Methods of treating cancer with anti-pd-1 antibodies
HK1247848A1
(en )
2018-10-05
Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
HK1251862A1
(en )
2019-04-26
Methods and compositons for treating cancer
IL264674B1
(en )
2023-05-01
Anti-siglec-7 antibodies for the treatment of cancer
EP3426777A4
(en )
2019-09-11
Combination vectors and methods for treating cancer
IL260474B
(en )
2020-08-31
Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment
EP3177292A4
(en )
2018-04-11
Compounds and methods for treating cancer
EP3589659A4
(en )
2021-03-24
Compounds and methods for treating cancer
EP3119426A4
(en )
2018-02-28
Methods and materials for treating cancer
EP3119427A4
(en )
2017-11-15
Methods and materials for treating cancer
EP3697767A4
(en )
2021-09-01
Compounds and methods for treating cancer
ZA201802618B
(en )
2019-09-25
Anti-cd43 antibody and use thereof for cancer treatment
EP3568145A4
(en )
2021-02-17
Materials and methods for treating cancer
EP3303289A4
(en )
2018-11-14
Compounds and methods for treating cancer
EP3273970A4
(en )
2018-09-12
Methods and materials for treating cancer
GB2571036B
(en )
2022-09-07
Aglycosylated antibody Fc region for treating cancer
PT3458478T
(en )
2021-02-26
Anti pd-1 and anti-lag3 antibodies for cancer treatment
GB201609402D0
(en )
2016-07-13
Materials and methods for treating cancer
GB201720089D0
(en )
2018-01-17
Means and methods for treating cancer